Related Experiment Videos
Antibodies: an alternative for antibiotics?
L R Berghman1, D Abi-Ghanem, S D Waghela
1Department of Poultry Science, Texas A&M University, College Station, Texas 77843-2472, USA. Berghman@poultry.tamu.edu
Poultry Science
|April 23, 2005
Summary
Passive immunization, using antibodies to fight infectious diseases, is regaining interest due to antibiotic resistance. Advances in antibody engineering and molecular farming show promise for future disease control strategies.
Area of Science:
- Immunology
- Microbiology
- Biotechnology
Background:
- The historical optimism regarding the eradication of infectious diseases has been challenged by their resurgence.
- Antibiotic resistance has emerged as a significant global health threat, necessitating alternative therapeutic strategies.
- Passive immunization, a historically significant approach, is being re-evaluated as a viable alternative to antibiotics.
Purpose of the Study:
- To review the historical context and limitations of passive immunization (serum therapy).
- To discuss the current applications of antibody administration in agricultural infectious disease management.
- To explore recent advancements in antibody engineering and molecular farming for therapeutic antibody production.
Main Methods:
- Literature review of historical and current research on passive immunization.
- Analysis of antibody engineering techniques and molecular farming applications.
- Evaluation of therapeutic antibody production in plant-based systems (e.g., corn, soybeans).
Main Results:
- Passive immunization, though once overshadowed by antibiotics, offers a valuable strategy against infectious diseases.
- Current agricultural practices utilize antibody administration for disease prophylaxis and treatment.
- Novel approaches like molecular farming demonstrate potential for cost-effective antibody production.
Conclusions:
- Passive immunization represents a critical, re-emerging strategy in combating infectious diseases, particularly in the face of antibiotic resistance.
- Advancements in antibody engineering and molecular farming, especially in staple crops, hold significant promise for future therapeutic applications.